Literature DB >> 24169522

New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update.

Claire Laure Navarro1, Vera Esteves-Vieira2, Sébastien Courrier1, Amandine Boyer2, Thuy Duong Nguyen3, Le Thi Thanh Huong4, Peter Meinke5, Winnie Schröder5, Valérie Cormier-Daire6, Yves Sznajer7, David J Amor8, Kristina Lagerstedt9, Martine Biervliet10, Peter C van den Akker11, Pierre Cau12, Patrice Roll12, Nicolas Lévy13, Catherine Badens13, Manfred Wehnert5, Annachiara De Sandre-Giovannoli13.   

Abstract

Restrictive dermopathy (RD) is a rare and extremely severe congenital genodermatosis, characterized by a tight rigid skin with erosions at flexure sites, multiple joint contractures, low bone density and pulmonary insufficiency generally leading to death in the perinatal period. RD is caused in most patients by compound heterozygous or homozygous ZMPSTE24 null mutations. This gene encodes a metalloprotease specifically involved in lamin A post-translational processing. Here, we report a total of 16 families for whom diagnosis and molecular defects were clearly established. Among them, we report seven new ZMPSTE24 mutations, identified in classical RD or Mandibulo-acral dysplasia (MAD) affected patients. We also report nine families with one or two affected children carrying the common, homozygous thymine insertion in exon 9 and demonstrate the lack of a founder effect. In addition, we describe several new ZMPSTE24 variants identified in unaffected controls or in patients affected with non-classical progeroid syndromes. In addition, this mutation update includes a comprehensive search of the literature on previously described ZMPSTE24 mutations and associated phenotypes. Our comprehensive analysis of the molecular pathology supported the general rule: complete loss-of-function of ZMPSTE24 leads to RD, whereas other less severe phenotypes are associated with at least one haploinsufficient allele.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24169522      PMCID: PMC4350588          DOI: 10.1038/ejhg.2013.258

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  47 in total

1.  Lamin a truncation in Hutchinson-Gilford progeria.

Authors:  Annachiara De Sandre-Giovannoli; Rafaëlle Bernard; Pierre Cau; Claire Navarro; Jeanne Amiel; Irène Boccaccio; Stanislas Lyonnet; Colin L Stewart; Arnold Munnich; Martine Le Merrer; Nicolas Lévy
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

2.  The CaaX motif of lamin A functions in conjunction with the nuclear localization signal to target assembly to the nuclear envelope.

Authors:  D Holtz; R A Tanaka; J Hartwig; F McKeon
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

3.  Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins.

Authors:  F D McKeon; M W Kirschner; D Caput
Journal:  Nature       Date:  1986 Feb 6-12       Impact factor: 49.962

4.  cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins.

Authors:  D Z Fisher; N Chaudhary; G Blobel
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability.

Authors:  Y Mori; J Yin; A Rashid; B A Leggett; J Young; L Simms; P M Kuehl; P Langenberg; S J Meltzer; O C Stine
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

6.  Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.

Authors:  Maria Eriksson; W Ted Brown; Leslie B Gordon; Michael W Glynn; Joel Singer; Laura Scott; Michael R Erdos; Christiane M Robbins; Tracy Y Moses; Peter Berglund; Amalia Dutra; Evgenia Pak; Sandra Durkin; Antonei B Csoka; Michael Boehnke; Thomas W Glover; Francis S Collins
Journal:  Nature       Date:  2003-04-25       Impact factor: 49.962

7.  Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy.

Authors:  Claire L Navarro; Annachiara De Sandre-Giovannoli; Rafaëlle Bernard; Irène Boccaccio; Amandine Boyer; David Geneviève; Smail Hadj-Rabia; Caroline Gaudy-Marqueste; Henk Sillevis Smitt; Pierre Vabres; Laurence Faivre; Alain Verloes; Ton Van Essen; Elisabeth Flori; Raoul Hennekam; Frits A Beemer; Nicole Laurent; Martine Le Merrer; Pierre Cau; Nicolas Lévy
Journal:  Hum Mol Genet       Date:  2004-08-18       Impact factor: 6.150

8.  Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia.

Authors:  Anil K Agarwal; Jean-Pierre Fryns; Richard J Auchus; Abhimanyu Garg
Journal:  Hum Mol Genet       Date:  2003-08-15       Impact factor: 6.150

9.  Restrictive dermopathy: report of two siblings.

Authors:  Chih-Sheng Lu; Shu-Chuan Wu; Jia-Woei Hou; Chih-Ping Chu; Lo-Lin Tseng; Hung-Chi Lue
Journal:  Pediatr Neonatol       Date:  2013-01-10       Impact factor: 2.083

10.  The processing pathway of prelamin A.

Authors:  M Sinensky; K Fantle; M Trujillo; T McLain; A Kupfer; M Dalton
Journal:  J Cell Sci       Date:  1994-01       Impact factor: 5.285

View more
  22 in total

Review 1.  Skin Disease in Laminopathy-Associated Premature Aging.

Authors:  Tomás McKenna; Agustín Sola Carvajal; Maria Eriksson
Journal:  J Invest Dermatol       Date:  2015-07-29       Impact factor: 8.551

Review 2.  A humanized yeast system to analyze cleavage of prelamin A by ZMPSTE24.

Authors:  Eric D Spear; Rebecca F Alford; Tim D Babatz; Kaitlin M Wood; Otto W Mossberg; Kamsi Odinammadu; Khurts Shilagardi; Jeffrey J Gray; Susan Michaelis
Journal:  Methods       Date:  2019-01-06       Impact factor: 3.608

3.  Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations.

Authors:  Davor Lessel; Ayse Bilge Ozel; Susan E Campbell; Abdelkrim Saadi; Martin F Arlt; Keisha Melodi McSweeney; Vasilica Plaiasu; Katalin Szakszon; Anna Szőllős; Cristina Rusu; Armando J Rojas; Jaime Lopez-Valdez; Holger Thiele; Peter Nürnberg; Deborah A Nickerson; Michael J Bamshad; Jun Z Li; Christian Kubisch; Thomas W Glover; Leslie B Gordon
Journal:  Hum Genet       Date:  2018-11-19       Impact factor: 4.132

Review 4.  Pharmacotherapy to gene editing: potential therapeutic approaches for Hutchinson-Gilford progeria syndrome.

Authors:  Saurabh Saxena; Sanjeev Kumar
Journal:  Geroscience       Date:  2020-02-11       Impact factor: 7.713

5.  Phenotypic heterogeneity of ZMPSTE24 deficiency.

Authors:  Thomas A Cassini; Amy K Robertson; Anna G Bican; Joy D Cogan; Vickie L Hannig; John H Newman; Rizwan Hamid; John A Phillips
Journal:  Am J Med Genet A       Date:  2018-01-17       Impact factor: 2.802

Review 6.  Mutations Involved in Premature-Ageing Syndromes.

Authors:  Fabio Coppedè
Journal:  Appl Clin Genet       Date:  2021-06-02

7.  Prelamin A processing, accumulation and distribution in normal cells and laminopathy disorders.

Authors:  Andrea Casasola; David Scalzo; Vivek Nandakumar; Jessica Halow; Félix Recillas-Targa; Mark Groudine; Héctor Rincón-Arano
Journal:  Nucleus       Date:  2016       Impact factor: 4.197

8.  Progeroid syndrome patients with ZMPSTE24 deficiency could benefit when treated with rapamycin and dimethylsulfoxide.

Authors:  Baris Akinci; Shireesha Sankella; Christopher Gilpin; Keiichi Ozono; Abhimanyu Garg; Anil K Agarwal
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-01

9.  A Heterozygous ZMPSTE24 Mutation Associated with Severe Metabolic Syndrome, Ectopic Fat Accumulation, and Dilated Cardiomyopathy.

Authors:  Damien Galant; Bénédicte Gaborit; Camille Desgrouas; Ines Abdesselam; Monique Bernard; Nicolas Levy; Françoise Merono; Catherine Coirault; Patrice Roll; Arnaud Lagarde; Nathalie Bonello-Palot; Patrice Bourgeois; Anne Dutour; Catherine Badens
Journal:  Cells       Date:  2016-04-25       Impact factor: 6.600

Review 10.  Physiological and Pathological Aging Affects Chromatin Dynamics, Structure and Function at the Nuclear Edge.

Authors:  Jérôme D Robin; Frédérique Magdinier
Journal:  Front Genet       Date:  2016-08-23       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.